Furthermore, we treated NRK-52E cells in the TGF-β1 group using the PI3K inhibitor wortmannin to investigate whether attenuating renal fibrosis in the TGF-β1 group was caused by inhibition of the PI3K/Akt pathway. Here, TGFB1 is linked to renal fibrosis.